There is a clear trajectory towards cohort ageing in the UK. HIV infection is associated with an increased prevalence of traditionally age-related comorbidities and geriatric syndromes. Some HIV services have been proactive in innovating models that cater for adapting needs. We aimed to describe how widespread this practice is and what form such services take.
Introduction
Prolonged survival with modern combined antiretroviral therapy (cART) coupled with ongoing later life acquisition of HIV are driving ageing of the HIV-positive cohort. UK data report that 48% of those accessing HIV services are aged ≥ 45 years [1] , with disproportionate increases seen in those of older ages over the past decade. HIV infection is associated with an increased prevalence of traditionally age-related comorbidities [2] and geriatric syndromes, such as frailty [3] , falls and functional decline [4] . Accordingly, there has been a paradigm shift in HIV care towards a chronic disease model [5] .
There is a question mark over whether HIV physicians and current service models are equipped to deal with the challenges faced by the ageing HIV-infected population, in terms of recognizing and managing age-related issues, or indeed whether it falls to HIV services to meet this need at all. Historically, people living with HIV (PLWH) have looked to their HIV clinic to coordinate their medical and, in some cases, their psychological and social care needs. HIV services have been proactive in innovating models that cater for the adapting needs of PLWH and there is evidence that clinics dedicated to ageing are in operation in the UK [6] . How widespread this activity is remains unknown. We therefore aimed to conduct a UK-wide evaluation of current provision of specialist ageing services, alongside clinicians' thoughts regarding the need for such services or formal guidance in this area.
Methods
We employed a web-based questionnaire (SurveyMonkey â Palo Alto, California, USA, www.surveymonkey.com), asking respondents to provide information on any existing or planned specialist ageing services within their centre. Where a service was present, we enquired into its model and function. If absent, we were interested to know if a service was in development, and if not whether it was felt to be necessary. In the absence of a specialist clinic, we sought to capture current working practices with regard to issues of ageing, including use of multidisciplinary team (MDT) meetings, access to allied health professionals, interactions with elderly medicine or primary care and screening practices. Lastly, we asked whether specific national guidance from the British HIV Association (BHIVA) on treating and/or monitoring older adults with HIV infection was desired. The questionnaire was administered via the BHIVA audit department to audit leads at HIV clinics.
This service evaluation project did not require formal ethical review according to the Health Research Authority. It was explicitly stated in the invitation email and questionnaire that participation was voluntary and respondents could complete the questionnaire anonymously if preferred. We sought optional consent, via a tick box option, to allow us to attribute responses to individual services. However, as such consent was not given universally, we will not name trusts or clinics directly. Data were analysed within the questionnaire software program, utilizing descriptive statistics only.
Results

Responding clinics
A total of 102 clinics responded. There are approximately 183 HIV clinics in the UK, giving a response rate of 55.7%. Figure 1 demonstrates the broad geographical spread of clinics.
The median clinic population size was 590 (range 30-4000). Clinics were predominantly hospital-based (47 of 83; 57%), then community-based (29 of 83; 35%) or split-sites (seven of 83; 8%). Five of the 102 clinics have a clinician with a special interest in ageing, with two of 102 providing a dedicated ageing service. The two existing services are based at larger clinics with cohorts of 2400 and 4000 patients, respectively. 
Existing specialist HIV ageing services
The two existing dedicated HIV ageing services demonstrate different models. The first, running for between 1 and 3 years, operates monthly with a geriatrician and HIV physician present as a joint clinic model. Referral criteria include a combination of age and need (including multimorbidity, polypharmacy and complexity). It operates as an in-person or virtual clinic offering a one-off review lasting 1 hour. The clinic offers comprehensive geriatric assessment, BHIVA-recommended screening and full medication review.
The second clinic has been operating weekly for > 5 years and is run by an HIV physician and clinical nurse specialist with an interest in ageing, without geriatrician involvement. The service is age-based and offers a one-off in-person review lasting 20 minutes. The clinic is linked to an MDT and offers comprehensive geriatric assessment, BHIVA-recommended screening, antiretroviral review, enhanced screening, primary prevention and functional review.
Perceived need for a specialist service
Where there is currently no specialist ageing service, 23% (23 of 98) of clinics reported a need for a dedicated ageing service, of which three are in development. Twothirds of clinics (63 of 98; 64%) reported no current need for a dedicated ageing service and 12 clinics were uncertain. Where no current need was reported, the most common reason given was insufficient clinic population (59%) and other reasons are summarized in Figure 2 . Some pertinent comments included "More than 50% of patients are over 50, so it forms part of standard care", "Consultants have practised inpatient care over many years so have experience", and "We have very good General Practitioners (GPs) who deal with ageing populations anyway".
Where there is no specialist service, half of clinics (51 of 97; 53%) would refer complex older adults on to a geriatrician, 70% (68 of 97) on to a GP, 16% (16 of 97) on to an allied health professional, and 16% (16 of 97) on to "other" (mainly specialists as indicated). [7] . 
Routine screening practices
BHIVA guidelines
The majority of responding clinics (65 of 95; 68%) would support the production of dedicated guidance for monitoring adults over 50 years old. Respondents felt that these should include standards for communication across specialties, broader information on screening for age-related problems, especially cognition (as well as non-AIDS-related cancer, falls, bone density, depression and cardiovascular risk), information on monitoring (renal function and lipid measurements), referral criteria to other specialties, standardized advice on didanosine, MDT management, and menopause/ erectile dysfunction issues. Other comments included "I feel over 50 is too young À over 60/65 is better", "How is this to be resourced?", "The role of primary care À we should not duplicate GP care but feed into it and other services".
Fewer respondents felt that dedicated guidance on ART for older adults was necessary, with 39 of 94 (41%) reporting a need, 39 of 94 (41%) reporting no need and 16 of 94 (17%) being uncertain. However, two clinics wanted more detailed guidance on switching/starting on specific antiretroviral backbones depending on cardiovascular risk and renal function.
Discussion
We have identified two existing and three proposed dedicated HIV ageing services. Another 20 clinics (20%) reported an unmet need for a specialist ageing service, suggesting that complex older adults may pose a management challenge. It should be noted, however, that two-thirds of respondents felt that no current need for such services exists, and, although a range of reasons were provided, the most commonly reported (by 60%) was insufficient population. This is important as, although there is no current need because of lack of a significant proportion of older adults within certain services, there is a clear trajectory towards cohort ageing within the UK [8] . This trend has been documented world-wide, with some recent modelling work from a study on the Dutch cohort, which has a similar demographic make-up to the UK HIV picture, predicting that by 2030 73% of PLWH will be aged > 50 years. This will be accompanied by higher burdens of comorbidities and nonantiretroviral medication use [9] . Therefore, we would anticipate clinic populations of older adults to grow in time, which may alter this perception of need.
Multidisciplinary working is integral to the successful management of older adults as a consequence of the interaction of health, functional and social issues that may underpin symptoms or health care service utilization. Reassuringly, the majority of clinics hold MDT meetings to discuss complex patients; however, currently only half use this as a forum to address issues of ageing. Yet again, this may reflect population need; however, it may also be a product of MDT make-up as less than half of the clinics reported access to allied health care practitioners, who may be more inclined to raise age-related problems. Rehabilitation for such issues for PLWH is certainly on the research agenda and no doubt will need to filter into clinical practice [10] .
Screening practices varied widely across the clinics surveyed. Two-thirds of clinics felt that they would like more specific guidance on the monitoring of people > 50 years old, although there was less support for Fig. 2 Reasons for lack of current need for a dedicated HIV ageing service (n = 73). Respondents were permitted to provide more than one answer. BHIVA, British HIV Association. specific treatment guidance. A forthcoming update of BHIVA monitoring guidelines may go some way to meeting this need.
We obtained no consensus on how issues of ageing should best be addressed for PLWH, because of the breadth of opinion. Partly, this may be attributable to differences in care providers across the centres, as some provision is by HIV physicians dually trained in general internal medicine, where there may be increased comfort in managing comorbidities and age-related problems. A study investigating this issue demonstrated that HIV and dually trained infectious disease physicians reported less comfort overall in treating such problems compared with those purely working in general medicine [11] .
Also, there remained uncertainty regarding the respective roles of GPs and HIV services in tackling age-related issues, especially in relation to screening and preventative medicine. GPs are incentivized and benchmarked on undertaking such activity, which may lead to duplication if the same investigations are performed as recommended in BHIVA monitoring guidelines. However, not all patients will disclose to their GP, favouring their HIV service as their primary access point for health care. This, coupled with problems associated with lack of knowledge around ART usage and co-prescribing [12] and suboptimal two-way communication between HIV services and primary care [13] , may limit the success of relying fully on primary care to take on these roles, especially as there is no consensus on shared-care models [14] , which are currently rare in the UK and, where present, are often ad hoc and locality-driven rather than formally commissioned, mostly in areas of high prevalence [15] .
HIV services have, however, been innovative in adapting to the changing needs of PLWH, making good use of specialist joint-clinic models to provide optimal services in certain diseases such as renal [16] and cardiovascular disease [17] . There is no reason why such a model would not work for ageing. This study has shown examples of geriatrician involvement as has other literature [18] . There is also an increasing literature aimed at informing geriatricians of the issues pertinent to ageing in PLWH [19, 20) .
The strengths of this survey include the broad geographical spread of responding clinics, including all four nations of the UK and a mix of hospital-and community-based clinics. However, we have not captured responses from all HIV services in the UK and so we may have underreported the number of specialist clinics already in operation within the UK. We asked for the audit lead from each clinic to respond on behalf of the clinic, but it is hard to ensure that the responses provided represent the views of the clinical staff as a whole rather than personal opinion.
In conclusion, to our knowledge this is the first survey of its kind to attempt to describe the current landscape and opinion around specific ageing services for PLWH in the UK. It is clear that services are already running or in development. HIV-infected cohorts will continue to age and current models of care may not fully meet their needs, which should prompt services, their users and commissioners to consider what models may best fit current and future demand. Such approaches may include improved ties to primary care, closer/joint working with geriatricians and/or enhanced use of the full MDT. It is likely that each service will need to be tailored to suit the individual clinic setting depending on specific need and available human resources.
